-+ 0.00%
-+ 0.00%
-+ 0.00%

BioCryst Pharma Q4 Sales $163.284M Beat $151.326M Estimate

Benzinga·02/26/2026 12:08:25
Listen to the news
BioCryst Pharma (NASDAQ:BCRX) reported quarterly sales of $163.284 million which beat the analyst consensus estimate of $151.326 million by 7.90 percent. This is a 24.14 percent increase over sales of $131.534 million the same period last year.